ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMA is expected to report earnings to -95 cents per share on August 07
Q2'26
Est.
$-0.95
Q1'26
Missed
by $0.75
Q4'25
Missed
by $0.11
Q2'25
Missed
by $0.55
The last earnings report on May 07 showed earnings per share of -94 cents, missing the estimate of -20 cents. With 2.00K shares outstanding, the current market capitalization sits at 66.21M.